A Systematic Review of Common Drug Review Pharmacoeconomic Submissions and an Analysis of Emerging Trends
Given financial constraints, drug manufacturers are required to provide pharmacoeconomic evaluations to demonstrate the value for money of their drug compared to current treatment when requesting reimbursement by publicly funded health care systems. This thesis is a retrospective examination of phar...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
Université d'Ottawa / University of Ottawa
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10393/30633 http://dx.doi.org/10.20381/ruor-6689 |